Fidia Farmaceutici, a multinational pharmaceutical Italian company and world leader in the research, development, manufacturing and marketing of products mainly based on hyaluronic acid and its derivatives, has acquired an integrated portfolio of anti-inflammatory drugs from Sanofi.
Gide assisted Fidia on French law aspects, together with Chiomenti (lead).
The Gide team advising Fidia comprised Jean-Gabriel Flandrois, partner, and Eya Ennaifer, associate, for corporate/M&A aspects and Magali Buchert, partner, Brian Martin and Manon Lorthiois, associates, for tax law aspects.
Chiomenti's team advising Fidia was headed by Luca Liistro, partner and head of Chiomenti's Pharma, Healthcare & Life Sciences Business Unit.
Jones Day (Paris) advised Sanofi.